HomeCompareJSPCF vs JNJ

JSPCF vs JNJ: Dividend Comparison 2026

JSPCF yields 3.64% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JSPCF wins by $1.14M in total portfolio value
10 years
JSPCF
JSPCF
● Live price
3.64%
Share price
$14.76
Annual div
$0.54
5Y div CAGR
60%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.17M
Annual income
$784,719.57
Full JSPCF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — JSPCF vs JNJ

📍 JSPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJSPCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JSPCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JSPCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JSPCF
Annual income on $10K today (after 15% tax)
$309.33/yr
After 10yr DRIP, annual income (after tax)
$667,011.63/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JSPCF beats the other by $663,025.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JSPCF + JNJ for your $10,000?

JSPCF: 50%JNJ: 50%
100% JNJ50/50100% JSPCF
Portfolio after 10yr
$600.4K
Annual income
$394,704.49/yr
Blended yield
65.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JSPCF
No analyst data
Altman Z
82.5
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JSPCF buys
0
JNJ buys
0
No recent congressional trades found for JSPCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJSPCFJNJ
Forward yield3.64%2.13%
Annual dividend / share$0.54$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR60%28%
Portfolio after 10y$1.17M$30.3K
Annual income after 10y$784,719.57$4,689.40
Total dividends collected$1.11M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JSPCF vs JNJ ($10,000, DRIP)

YearJSPCF PortfolioJSPCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,282$582.27$10,592$272.30+$690.00JSPCF
2$13,054$982.32$11,289$357.73+$1.8KJSPCF
3$15,668$1,699.61$12,123$472.89+$3.5KJSPCF
4$19,815$3,050.26$13,141$629.86+$6.7KJSPCF
5$26,970$5,768.39$14,408$846.81+$12.6KJSPCF
6$40,599$11,740.48$16,021$1,151.60+$24.6KJSPCF
7$69,868$26,427.08$18,122$1,588.22+$51.7KJSPCF
8$142,765$68,006.46$20,930$2,228.20+$121.8KJSPCF
9$360,552$207,793.40$24,792$3,191.91+$335.8KJSPCF
10$1,170,510$784,719.57$30,274$4,689.40+$1.14MJSPCF

JSPCF vs JNJ: Complete Analysis 2026

JSPCFStock

JSP Corporation manufactures and sells expanded polymers worldwide. The company offers materials products, such as ARPRO, an impact energy management material that is used in automotive applications, multi-use transport packaging, HVAC housings, and others; STYRODIA for use in various applications comprising packaging for consumer electronics, hot and cold food containers, construction insulation, and within civil engineering materials; and FOAMCORE that is used in prefabricated bathrooms and automotive components. It also provides sheet and board products under the MIRAMAT, CAPLON, P-BOARD, STYRENE PAPER, MIRABOARD, and MIRAFOAM names for advertising boards, construction, food packaging, and industrial packaging markets. The company was incorporated in 1962 and is headquartered in Tokyo, Japan. JSP Corporation is a subsidiary of Mitsubishi Gas Chemical Company, Inc.

Full JSPCF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this JSPCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JSPCF vs SCHDJSPCF vs JEPIJSPCF vs OJSPCF vs KOJSPCF vs MAINJSPCF vs ABBVJSPCF vs MRKJSPCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.